IP Library Granted Patent US 12,589,396
Granted Patent B2
US 12,589,396 · App. 18/129,775 · Granted Mar 31, 2026

Digital to biological converter

Inventors: J. Craig Venter (La Jolla, CA); Daniel Gibson (Carlsbad, CA); John E. Gill (San Marcos, CA)
B01L7/52C07K14/005C12N7/00C12N15/1089C12N15/1093C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,589,396
App. No.
18/129,775
Granted
Mar 31, 2026
Kind
B2
Abstract

The present invention provides a system for receiving biological sequence information and activating the synthesis of a biological entity. The system has a receiving unit for receiving a signal encoding biological sequence information transmitted from a transmitting unit. The transmitting unit can be present at a remote location from the receiving unit. The system also has an assembly unit connected to the receiving unit, and the assembly unit assembles the biological entity according to the biological sequence information. Thus, according to the present invention biological sequence information can be digitally transmitted to a remote location and the information converted into a biological entity, for example a protein useful as a vaccine, immediately upon being received by the receiving unit and without further human intervention after preparing the system for receipt of the information. The invention is useful, for example, for rapidly responding to viral and other biological threats that are specific to a particular locale.

Claims (28)

1 . A method of synthesizing a double-stranded DNA (dsDNA) molecule according to provided biological sequence information comprising:

providing a system comprising an assembly unit that assembles the double-stranded DNA molecule according to the biological sequence information;

providing within or connected to the assembly unit vessels containing a plurality of oligonucleotide molecules and reagents for performing reactions to synthesize the dsDNA molecule;

and components that transport the reagents within the system and that execute steps in an automated method for synthesizing the dsDNA molecule; and wherein the method comprises the assembly of one or more dsDNA molecules by joining the plurality of oligonucleotides, and wherein no human intervention occurs after the method is initiated and until the dsDNA molecule is synthesized; and

wherein the system further comprises a non-transitory computer readable medium containing software programming instructions that direct steps in the assembly unit for the assembly of the plurality of oligonucleotide molecules into the dsDNA molecule in the automated method;

wherein the software programming instructions direct a step of PCR amplification in a first reaction zone of a reaction container, a step of error correction in a second reaction zone of a reaction container performed after the step of PCR amplification, a step of DNA assembly in a third reaction zone of a reaction container, and directs the transport of reagents from one reaction zone to the next, and wherein the reaction container is a reaction plate, and the reaction zones comprise one or more reaction wells on the reaction plate; and

wherein the system further comprises a robotic arm configured to transfer the oligonucleotide molecules from the first reaction zone to the second reaction zone, the oligonucleotide molecules successively accumulating in each reaction zone;

initiating the automated method; and

thereby synthesizing the dsDNA molecule in an automated method.

2 . The method of claim 1 wherein the system further comprises a transmitting unit and wherein the receiving unit are computers that are part of a computer network.

3 . The method of claim 1 wherein the oligonucleotides are provided to a sub-unit of the assembly unit for amplification of the oligonucleotides by the step of PCR.

4 . The method of claim 1 wherein the oligonucleotides are from 40-100 nucleotides in length.

5 . The method of claim 1 wherein the system further comprises software programming instructions and reagents directing steps for the transcription of the DNA molecule into an RNA molecule.

6 . The method of claim 5 wherein the system further comprises software programming instructions and reagents directing translation of the RNA molecule into a protein molecule.

7 . The method of claim 6 wherein the protein is further processed by the system to produce a virus particle or a portion of a virus particle.

8 . The method of claim 7 wherein the virus particle or portion of a virus particle comprises a protein antigen.

9 . The method of claim 1 wherein the assembly unit further comprises or is connected to a vessel comprising a host cell.

10 . The method of claim 1 wherein the system comprises a single reaction container.

11 . The method of claim 10 wherein the reaction container is a 96 well plate.

12 . The method of claim 1 wherein the reaction container is a 96 well plate having dimensions of about 127 mm×about 85 mm.

13 . The method of claim 1 wherein the double stranded DNA molecule is greater than 500 bp in size.

14 . The method of claim 1 wherein the assembly unit further comprises or is connected to vessels containing a nucleic acid molecule selected from the group consisting of: a plasmid, a vector, a regulatory sequence, a promoter sequence, a binding element for a trans-acting factor, and a signal sequence.

15 . The method of claim 1 wherein the plurality of oligonucleotide molecules are 30-110 nucleotides in length.

16 . The method of claim 1 further comprising assembling the oligonucleotides in an isothermal reaction.

17 . The method of claim 1 wherein the plurality of oligonucleotide molecules are assembled into the dsDNA molecule(s) in a simultaneous reaction.

18 . The method of claim 1 wherein the overlapping oligonucleotides are assembled in a reaction using an exonuclease and a DNA polymerase.

19 . The method of claim 1 further comprising synthesizing the dsDNA molecule into a plasmid or vector for further use.

20 . The method of claim 1 further comprising appending regulatory sequences or promoter sequence to the assembled dsDNA molecule.

Assignments (8)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
SECURITY AGREEMENT SUPPLEMENT (TERM) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 066372/0745 →
SECURITY AGREEMENT SUPPLEMENT (REVOLVING) Recorded Jan 26, 2024
From: TELESIS BIO INC.; ETONBIO, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 066372/0761 →
CHANGE OF NAME Recorded May 30, 2023
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 063803/0915 →
CHANGE OF NAME Recorded May 30, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063803/0947 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2023
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 063799/0617 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2023
From: VENTER, J. CRAIG; GIBSON, DANIEL G.; GILL, JOHN E.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 063799/0558 →
Continuity (5)
Continuation 17321301 · May 14, 2021
Continuation 15654306 · Jul 19, 2017
Continuation 13969215 · Aug 16, 2013
Provisional Application 61684076 · Aug 16, 2012
Related Publication 20230264202A1 · Aug 24, 2023
References Cited (60)
US 7118883B2 · Inoue et al. · 2006 [cited by applicant]
US 7164992B1 · Mulligan et al. · 2007 [cited by applicant]
US 7662617B2 · Rush · 2010 [cited by applicant]
US 7923533B2 · Hyde et al. · 2011 [cited by applicant]
US 8033047B2 · Rasmussen et al. · 2011 [cited by applicant]
US 8110395B2 · Lewnard et al. · 2012 [cited by applicant]
US 20040223885A1 · Keen et al. · 2004 [cited by applicant]
US 20050267971A1 · Fritz · 2005 [cited by applicant]
US 20070269870A1 · Church et al. · 2007 [cited by applicant]
US 20100035768A1 · Gibson et al. · 2010 [cited by applicant]
US 20110124049A1 · Li et al. · 2011 [cited by applicant]
US 20110207624A1 · Shen et al. · 2011 [cited by applicant]
US 20110250649A1 · Li et al. · 2011 [cited by applicant]
US 20120028843A1 · Ramu et al. · 2012 [cited by applicant]
US 20120052560A1 · Knight et al. · 2012 [cited by applicant]
US 20120220497A1 · Jacobson et al. · 2012 [cited by applicant]
US 20130296194A1 · Jacobson et al. · 2013 [cited by applicant]
US 20150031088A1 · Tian · 2015 [cited by applicant]
US 20160144332A1 · Chu · 2016 [cited by applicant]
JP H08506813A · 1996 [cited by applicant]
JP 2008523786A · 2008 [cited by applicant]
WO WO9914318A1 · 1999 [cited by applicant]
WO WO2002053582A2 · 2002 [cited by applicant]
WO WO2004070047A1 · 2004 [cited by applicant]
WO WO2004099435A2 · 2004 [cited by applicant]
WO WO2005059097A2 · 2005 [cited by applicant]
WO WO2006044596A2 · 2006 [cited by applicant]
WO WO2006044956A1 · 2006 [cited by applicant]
WO WO2006076679A1 · 2006 [cited by applicant]
WO WO2008024319A2 · 2008 [cited by applicant]
WO WO2008028024A2 · 2008 [cited by applicant]
WO WO2009020435A1 · 2009 [cited by applicant]
WO WO2009103027A2 · 2009 [cited by applicant]
EP Extended Search Report in European Application No. 22215974.1, dated Jun. 20, 2023, 15 pages. [cited by applicant]
Alemdargolu et al., “Generation of Multiblock Copolymers by PCR: Synthesis, Visualization and Nanomechanical Properties,” Nano Letters, American Chemical Society, US, Oct. 14, 2009, vol. 09, No. 10, pp. 3658-3662. [cited by applicant]
Communication Pursuant to Rules 70(2) and 70a(2) for European Application No. 13829140.6, mailed Apr. 7, 2016, 1 Pages. [cited by applicant]
Densmore et al., “Algorithms for Automated DNA Assembly,” Nucleic Acids Research, 2010, vol. 38, No. 08, pp. 2607-2616. [cited by applicant]
Ellis et al., “DNA Assembly for Synthetic Biology: from Parts to Pathways and Beyond,” Integrative Biology, Jan. 2011, vol. 03, No. 02, pp. 109-118. [cited by applicant]
European Examination Report for European Application No. 13829140.6, mailed Jul. 2, 2019, 6 Pages. [cited by applicant]
European Examination Report for European Application No. 13829140.6, mailed Dec. 13, 2016, 6 Pages. [cited by applicant]
European Examination Report for European Application No. 13829140.6, mailed May 28, 2018, 7 Pages. [cited by applicant]
Extended European Search Report for European Application No. 13829140.6, mailed Mar. 21, 2016, 10 Pages. [cited by applicant]
Geall et al., “Nonviral Delivery of Self-Amplifying RNA Vaccines,” Proceedings of the National Academy of Sciences of the United States of America, Jul. 26, 2012, vol. 109, No. 36, 6 Pages. [cited by applicant]
Gibson et al., “Chemical Synthesis of the Mouse Mitochondrial Genome,” Nature Methods, Nature Pub. Group, Nov. 2010, vol. 07, No. 11, pp. 901-903. [cited by applicant]
Gibson et al., “Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome,” Science, Jul. 2, 2010, vol. 329, No. 5987, pp. 52-56. [cited by applicant]
Gibson et al., “Enzymatic Assembly of DNA Molecules up to Several Hundred Kilobases”, Nature Methods, May 2009, vol. 6, No. 5, pp. 343-345, 5 Pages. [cited by applicant]
Hekele et al., “Rapidly Produced SAM® Vaccine Against H7N9 Influenza is Immunogenic in Mice,” Emerging Microbes and Infections, Aug. 14, 2013, vol. 2:e52, 7 Pages. [cited by applicant]
Hillson et al., “j5 DNA Assembly Design Automation Software,” ACS Synthetic Biology, Jan. 20, 2012, vol. 01, No. 01, pp. 14-21. [cited by applicant]
Huang et al., “Integrated Two-Step Gene Synthesis in a Microfluidic Device,” Lab on a Chip, Mar. 2009, vol. 9, No. 02, pp. 276-285. [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2013/055454, mailed Dec. 16, 2013, 14 Pages. [cited by applicant]
Li et al., “Impedance Sensing of DNA Binding Drugs using Gold Substrates Modified with Gold Nanoparticles,” Analytical Chemistry, Jan. 15, 2005, vol. 77, No. 02, pp. 478-485. [cited by applicant]
Ma et al., “DNA Synthesis, Assembly and Applications in Synthetic Biology,” Current Opinion in Chemical Biology, Aug. 2012, vol. 16, No. 3-4, pp. 260-267. [cited by applicant]
Ma et al., “Error Correction in Gene Synthesis Technology,” Trends in Biotechnology, Mar. 2012, vol. 30, No. 03, pp. 147-154, DOI: 10.1016/j.tibtech.2011.10.002. [cited by applicant]
New England Biolab Product Data Sheet M0206S Sold Since 2012, 2 Pages. [cited by applicant]
Notice of Reasons for Rejection for Japanese Patent Application No. 2015-527674, mailed Jun. 21, 2017, 14 Pages. [cited by applicant]
Notice of Reasons for Rejection for Japanese Patent Application No. 2015-527674, mailed Apr. 26, 2018, 10 Pages. [cited by applicant]
Notka et al., “Industrial Scale Gene Synthesis,” Methods in Enzymology, Academic Press, USA, Jan. 2011, vol. 498, pp. 247-275. [cited by applicant]
Quan et al., “Parallel On-Chip Gene Synthesis and Application to Optimization of Protein Expression,” Nature Biotechnology, May 2011, vol. 29, No. 05, pp. 449-452. [cited by applicant]
Rocquigny et al., “First Large Scale Chemical Synthesis of The 72 Amino Acid HIV-1 Nucleocapsid Protein NCp7 in an Active Form,” Biochemical and Biophysical Research Communications, Oct. 31, 1991. Vol. 180. No. 2, pp. 1… [cited by applicant]
Xiong et al., “Chemical Gene Synthesis: Strategies, Softwares, Error Corrections, and Applications,” FEMS Microbiology Reviews, May 2008, vol. 32, No. 03, pp. 522-540. [cited by applicant]